Gary Sender Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary Sender.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary Sender. Gary Sender is a Director in Schrodinger, Inc. ($SDGR) and a Chief Financial Officer in Nabriva Therapeutics AG ($NBRV) and a Chief Financial Officer in Nabriva Therapeutics Plc ($NBRV) and a Director in Harmony Biosciences Holdings, Inc. ($HRMY).
Address: C/O SYNERGY PHARMACEUTICALS INC., 420 LEXINGTON AVENUE, SUITE 2012 NEW YORK 10170 NY
Companies in which Gary Sender is an Insider
Harmony Biosciences Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Sender: Director
Holdings: 0 shares
Latest Transaction: Aug 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics Legacy plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Sender: Chief Financial Officer
Holdings: 2,200 shares
Latest Transaction: Jun 28 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Sender: Chief Financial Officer
Holdings: 20,503 shares
Current Value: $165,869
Latest Transaction: Feb 02 2021
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Schrodinger, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Sender: Director
Holdings: 15,885 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gary Sender
Sentiment: All, HRMY, NBRV, NBRV, SDGR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Option Exercise | M | 17.00 | 12,890 | 219,130 | 19 | |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Option Exercise | M | 5.31 | 15,885 | 84,349 | 24,246 | |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Sell | S | 66.55 | 28,775 | 1,914,838 | 0 | 28.8 K to 0 (-100.00 %) |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Buy | M | 17.00 | 12,890 | 219,130 | 28,775 | 15.9 K to 28.8 K (+81.15 %) |
| Mar 10 2021 | SDGR | Schrodinger, Inc. | Sender Gary | Director | Buy | M | 5.31 | 15,885 | 84,349 | 15,885 | 0 to 15.9 K |
| Feb 02 2021 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 2.62 | 37 | 97 | 20,503 | 20.5 K to 20.5 K (-0.18 %) |
| Jan 05 2021 | NBRV | Nabriva Therapeuti ... | Sender Gary | Chief Financial Off ... | Payment of Exercise | F | 2.42 | 32 | 77 | 20,540 | 20.6 K to 20.5 K (-0.16 %) |